Activity Stream
@moatrx
• 2 weeks ago
Posted a new blog:
GCC ATTR AMYLOIDOSIS LAUNCH READINESS
GCC ATTR AMYLOIDOSIS LAUNCH READINESS
No ATTR-CM treatment is SFDA-registered in the GCC, so a first-mover drug still has almost no diagnosed patients without Tc-PYP expansion.
Tafamidis (Vyndaqel) is...
